Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7283 p79
24 January 2004

This article
Reprint
Photocopy


News summary

Related websites
Hypertension abstract (more)


Repeated melatonin reduces night-time blood pressure

Repeated doses of melatonin reduce nocturnal blood pressure, a new study shows.

The finding suggests that enhanced functioning of the biological clock could one day be used as a strategy for the treatment of hypertension.

Researchers from the Netherlands Institute for Brain Research, Amsterdam, examined the effect on blood pressure of a single dose of oral melatonin (2.5mg) and that of repeated doses (2.5mg daily for three weeks) given one hour before bedtime. They found that, compared with placebo, repeated doses reduced systolic and diastolic blood pressure during sleep by 6mmHg and 4mmHg, respectively.

A single dose of melatonin had no effect on blood pressure.

“Support of circadian pacemaker function may provide a new strategy in the treatment of essential hypertension,” they suggest. However, the researchers acknowledge that improved sleep, reported by patients taking melatonin, could have helped reduce blood pressure.

The crossover study, which involved 16 men with untreated essential hypertension, is published online in the rapid access issue of Hypertension.

Dan Jones, a spokesman for the American Heart Association, said that the report was of interest primarily at a research level. “Larger studies certainly would be needed prior to recommending this approach to patients with high blood pressure,” he added.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal